DEMSHUR DAVID M 4
4 · CORE LABORATORIES N V · Filed Jan 3, 2020
Insider Transaction Report
Form 4
DEMSHUR DAVID M
DirectorChief Executive Officer
Transactions
- Tax Payment
Common Shares
2019-12-31$37.67/sh−19,274$726,052→ 365,844 total - Exercise/Conversion
Common Shares
2019-12-31+59,100→ 385,118 total - Exercise/Conversion
Performance Shares
2019-12-31−59,100→ 0 totalExercise: $0.00→ Common Shares (59,100 underlying)
Holdings
- 68,530(indirect: By 401(k))
Common Shares
Footnotes (1)
- [F1]The shares vesting were awarded as restricted performance shares in February 2017 as reported in the Form 4 filing on February 16, 2017. This filing states that 50% of the restricted performance shares will vest at the end of the Performance Period if the Company is in the top 50th ROIC percentile among a Bloomberg Peer Group(BPG), 100% of the award will vest if the Company is in the top 75th ROIC percentile of the BPG and 150% of the award will vest if the Company is the top performing ROIC company of the BPG. The Company was the top performing ROIC company as of the end of the performance period and as such the performance criteria and all requirements for full vesting have been met and thus the shares granted in February 2017 vested on December 31, 2019, at the conclusion of the performance period.